Sánchez de la Nava, A.M.; Gómez-Cid, L.; Ríos-Muñoz, G.R.; Fernández-Santos, M.E.; Fernández, A.I.; Arenal, Á.; Sanz-Ruiz, R.; Grigorian-Shamagian, L.; Atienza, F.; Fernández-Avilés, F.
Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic. BioTech 2022, 11, 23.
https://doi.org/10.3390/biotech11030023
AMA Style
Sánchez de la Nava AM, Gómez-Cid L, Ríos-Muñoz GR, Fernández-Santos ME, Fernández AI, Arenal Á, Sanz-Ruiz R, Grigorian-Shamagian L, Atienza F, Fernández-Avilés F.
Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic. BioTech. 2022; 11(3):23.
https://doi.org/10.3390/biotech11030023
Chicago/Turabian Style
Sánchez de la Nava, Ana María, Lidia Gómez-Cid, Gonzalo Ricardo Ríos-Muñoz, María Eugenia Fernández-Santos, Ana I. Fernández, Ángel Arenal, Ricardo Sanz-Ruiz, Lilian Grigorian-Shamagian, Felipe Atienza, and Francisco Fernández-Avilés.
2022. "Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic" BioTech 11, no. 3: 23.
https://doi.org/10.3390/biotech11030023
APA Style
Sánchez de la Nava, A. M., Gómez-Cid, L., Ríos-Muñoz, G. R., Fernández-Santos, M. E., Fernández, A. I., Arenal, Á., Sanz-Ruiz, R., Grigorian-Shamagian, L., Atienza, F., & Fernández-Avilés, F.
(2022). Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic. BioTech, 11(3), 23.
https://doi.org/10.3390/biotech11030023